Aadi Capital Expenditures vs Free Cash Flow Analysis

AADI Stock  USD 2.41  0.01  0.41%   
Aadi Bioscience financial indicator trend analysis is way more than just evaluating Aadi Bioscience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aadi Bioscience is a good investment. Please check the relationship between Aadi Bioscience Capital Expenditures and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Capital Expenditures vs Free Cash Flow

JavaScript chart by amCharts 3.21.15201420162018202020222024500K1M1.5M2M2.5M3M3.5M4M -60M-55M-50M-45M-40M-35M-30M-25M-20M-15M-10M-5M
JavaScript chart by amCharts 3.21.15Capital Expenditurestotal: 9.1MFree Cash Flowtotal: -292M

Capital Expenditures vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aadi Bioscience Capital Expenditures account and Free Cash Flow. At this time, the significance of the direction appears to have pay attention.
Capital ExpendituresFree Cash FlowDiversified AwayCapital ExpendituresFree Cash FlowDiversified Away100%
The correlation between Aadi Bioscience's Capital Expenditures and Free Cash Flow is -0.83. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Aadi Bioscience, assuming nothing else is changed. The correlation between historical values of Aadi Bioscience's Capital Expenditures and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Aadi Bioscience are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Capital Expenditures i.e., Aadi Bioscience's Capital Expenditures and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.83
Relationship DirectionNegative 
Relationship StrengthSignificant

Capital Expenditures

Capital Expenditures are funds used by Aadi Bioscience to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aadi Bioscience operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Aadi Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Enterprise Value Multiple is increasing as compared to previous years.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation105K159K171K122.1K
Interest Income13K2.4M6.5M6.8M

Aadi Bioscience fundamental ratios Correlations

0.99-0.79-0.850.81.00.840.951.0-0.110.650.930.810.73-0.210.450.880.880.960.880.960.670.740.73-0.390.66
0.99-0.81-0.830.811.00.80.940.99-0.230.530.90.80.63-0.320.480.850.830.950.850.950.630.70.73-0.440.62
-0.79-0.810.63-1.0-0.8-0.45-0.74-0.780.28-0.35-0.69-0.62-0.430.33-0.56-0.58-0.77-0.83-0.72-0.75-0.38-0.66-0.190.26-0.37
-0.85-0.830.63-0.66-0.83-0.85-0.95-0.850.0-0.68-0.83-0.44-0.70.1-0.56-0.93-0.8-0.85-0.84-0.8-0.82-0.8-0.610.27-0.81
0.80.81-1.0-0.660.810.480.750.8-0.190.420.720.630.5-0.250.540.610.80.840.750.760.40.680.2-0.240.4
1.01.0-0.8-0.830.810.790.931.0-0.150.580.90.830.68-0.240.470.840.840.950.840.950.610.720.73-0.410.6
0.840.8-0.45-0.850.480.790.880.83-0.050.70.930.480.72-0.170.190.970.820.830.910.870.940.580.75-0.460.94
0.950.94-0.74-0.950.750.930.880.95-0.160.640.910.60.69-0.260.580.940.860.930.890.90.790.820.68-0.310.79
1.00.99-0.78-0.850.81.00.830.95-0.110.640.930.810.73-0.210.460.870.870.960.870.950.660.740.74-0.380.65
-0.11-0.230.280.0-0.19-0.15-0.05-0.16-0.110.55-0.05-0.020.50.99-0.28-0.050.02-0.14-0.07-0.11-0.030.02-0.030.31-0.03
0.650.53-0.35-0.680.420.580.70.640.640.550.720.430.990.440.130.710.790.610.70.630.680.680.470.020.68
0.930.9-0.69-0.830.720.90.930.910.93-0.050.720.690.78-0.170.210.940.950.950.980.980.830.630.67-0.510.83
0.810.8-0.62-0.440.630.830.480.60.81-0.020.430.690.57-0.070.160.470.630.730.560.780.190.440.68-0.40.18
0.730.63-0.43-0.70.50.680.720.690.730.50.990.780.570.390.150.730.830.690.740.710.650.70.55-0.050.65
-0.21-0.320.330.1-0.25-0.24-0.17-0.26-0.210.990.44-0.17-0.070.39-0.3-0.17-0.09-0.23-0.19-0.22-0.15-0.07-0.110.32-0.15
0.450.48-0.56-0.560.540.470.190.580.46-0.280.130.210.160.15-0.30.330.290.360.220.230.170.780.160.30.17
0.880.85-0.58-0.930.610.840.970.940.87-0.050.710.940.470.73-0.170.330.860.890.940.890.930.670.68-0.420.93
0.880.83-0.77-0.80.80.840.820.860.870.020.790.950.630.83-0.090.290.860.910.960.920.770.740.47-0.350.77
0.960.95-0.83-0.850.840.950.830.930.96-0.140.610.950.730.69-0.230.360.890.910.940.970.720.660.61-0.490.72
0.880.85-0.72-0.840.750.840.910.890.87-0.070.70.980.560.74-0.190.220.940.960.940.950.870.620.53-0.50.87
0.960.95-0.75-0.80.760.950.870.90.95-0.110.630.980.780.71-0.220.230.890.920.970.950.730.60.69-0.580.73
0.670.63-0.38-0.820.40.610.940.790.66-0.030.680.830.190.65-0.150.170.930.770.720.870.730.540.52-0.361.0
0.740.7-0.66-0.80.680.720.580.820.740.020.680.630.440.7-0.070.780.670.740.660.620.60.540.410.160.54
0.730.73-0.19-0.610.20.730.750.680.74-0.030.470.670.680.55-0.110.160.680.470.610.530.690.520.41-0.410.51
-0.39-0.440.260.27-0.24-0.41-0.46-0.31-0.380.310.02-0.51-0.4-0.050.320.3-0.42-0.35-0.49-0.5-0.58-0.360.16-0.41-0.35
0.660.62-0.37-0.810.40.60.940.790.65-0.030.680.830.180.65-0.150.170.930.770.720.870.731.00.540.51-0.35
Click cells to compare fundamentals

Aadi Bioscience Account Relationship Matchups

Aadi Bioscience fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets39.9M18.8M157.9M184.2M132.4M139.0M
Total Stockholder Equity36.5M(12.4M)136.4M158.4M105.2M110.5M
Net Debt(38.4M)5.8M(148.4M)(37.4M)(61.6M)(58.5M)
Retained Earnings(142.2M)(32.6M)(142.7M)(203.2M)(269.0M)(255.5M)
Cash38.5M4.5M149.0M39.0M62.9M66.0M
Cash And Short Term Investments38.5M4.5M149.0M172.6M108.8M114.3M
Common Stock Shares Outstanding2.7M2.5M8.9M22.5M26.9M28.3M
Liabilities And Stockholders Equity39.9M18.8M157.9M184.2M132.4M139.0M
Other Stockholder Equity179.1M20.2M279.1M361.7M374.1M392.8M
Total Current Assets39.6M18.7M151.3M180.0M124.6M130.8M
Total Current Liabilities3.3M30.1M15.3M18.8M26.4M27.7M
Total Liab3.4M31.3M21.5M25.9M27.2M28.6M
Other Current Liab2.8M99K8.7M14.5M20.1M21.1M
Accounts Payable439.8K2.4M6.4M3.5M5.9M6.2M
Other Current Assets1.0M81K4.6M3.7M3.8M4.0M
Non Current Assets Total366.3K140K6.6M4.2M7.8M8.2M
Non Currrent Assets Other40.0K(140K)2.2M2.1M1.9M2.0M
Property Plant And Equipment Net326.3K140K614K2.0M6.0M6.3M
Accumulated Other Comprehensive Income(335.8K)(311.1K)(328.9K)(115K)27K28.4K
Property Plant And Equipment Gross326.3K185.6K614K2.0M6.2M6.6M
Net Tangible Assets(9.1M)43.1M132.6M158.4M182.1M191.2M
Property Plant Equipment316.0K121.7K57K2.0M2.3M2.5M

Currently Active Assets on Macroaxis

When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.28)
Revenue Per Share
0.929
Quarterly Revenue Growth
0.21
Return On Assets
(0.35)
Return On Equity
(0.66)
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.